Abstract
A magnetic resonance imaging (MRI)-directed ultrasound (US), also known as second-look US or targeted US, is performed to assess for a sonographic correlate for a lesion detected by MRI that was not initially seen at mammography or ultrasound. If a correlate is seen at ultrasound, US-guided biopsy is the preferred method as it can be less expensive, faster, easier, and more comfortable for patients than MRI-guided biopsy. Understanding the differences in breast position between MRI (prone) and ultrasound (supine) in addition to knowledge of the location and morphology of the MRI-detected lesion can aid in identifying a sonographic correlate. Performing imaging-histopathologic concordance and imaging follow-up are important in patient management. In the absence of a sonographic correlate, MRI-guided biopsy is still required of any lesion deemed suspicious at MR imaging.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abe H, Schmidt R, Shah R, Shimauchi A, Kulkarni K, Sennett C, et al. MR-directed (“second-look”) ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR. 2010;194(2):370–7.
Bluemke DA, Gatsonis CA, Chen MH, DeAngelis GA, DeBruhl N, Harms S, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004;292(22):2735.
Candelaria R, Fornage BD. Second-look US examination of MR-detected breast lesions. J Clin Ultrasound. 2011;39:115–21.
Carbonaro L, Tannaphai P, Trimboli R, Verardi N, Fedeli M, Sardanelli F. Contrast enhanced breast MRI: spatial displacement from prone to supine patient’s position. Preliminary results. Eur J Radiol. 2012;81(6):e771–4.
DeMartini W, Eby P, Peacock S, Lehman C. Utility of targeted sonography for breast lesions that were suspicious on MRI. AJR. 2009;192(4):1128–34.
Destounis S, Arieno A, Somerville PA, Seifert PJ, Murphy P, Morgan R, et al. Community-based practice experience of unsuspected breast magnetic resonance imaging abnormalities evaluated with second-look sonography. J Ultrasound Med. 2009;28:1337–46.
Hollowell L, Price E, Arasu V, Wisner D, Hylton N, Joe B. Lesion morphology on breast MRI affects targeted ultrasound correlation rate. Eur Radiol. 2015;25:1279–84.
Hong M, Cha J, Kim H, Shin H, Chae E, Shin J, et al. Second-look ultrasonography for MRI-detected suspicious breast lesions in patients with breast cancer. Ultrasonography. 2014;34(2):125–32.
Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23(33):8469–76.
LaTrenta LR, Menell JH, Morris EA, Abramson AF, Dershaw DD, Liberman L. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology. 2003;227:856–61.
Lehman C, Isaacs C, Schnall M, Pisano E, Ascher S, Weatherall P, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study 1. Radiology. 2007;244(2):381–8.
Leung J. Utility of second-look ultrasound in the evaluation of MRI-detected breast lesions. Semin Roentgenol. 2011;46(4):260–74.
Meissnitzer M, Dershaw D, Lee C, Morris E. Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommended. AJR. 2009;193(4):1025–9.
Monticciolo D. Postbiopsy confirmation of MR-detected lesions biopsied using ultrasound. AJR. 2012;198(6):W618–20.
Morris E, Liberman L, Ballon D, Robson M, Abramson A, Heerdt A, et al. MRI of occult breast carcinoma in a high-risk population. AJR. 2003;181(3):619–26.
Morris EA, Comstock CE, Lee CH, et al. ACR BI-RADS® Magnetic Resonance Imaging. In: ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. Reston: American College of Radiology; 2013.
Nouri-Neuville M, de Rocquancourt A, Cohen-Zarade S, Chapellier-Canaud M, Albiter M, Hamy A, et al. Correlation between MRI and biopsies under second look ultrasound. Diagn Interv Radiol. 2014;95(2):197–211.
Orel S, Schnall M. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220(1):13–30.
Park V, Kim M, Kim E, Moon H. Second-look US: how to find breast lesions with a suspicious MR imaging appearance. Radiographics. 2013;33(5):1361–75.
Sardanelli F, Podo F, D’Agnolo G, Verdecchia A, Santaquilani M, Musumeci R, et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results 1. Radiology. 2007;242(3):698–715.
Sim L, Hendriks J, Bult P, Fook-Chong S. US correlation for MRI-detected breast lesions in women with familial risk of breast cancer. Clin Radiol. 2005;60(7):801–6.
Spick C, Baltzer P. Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis. Radiology. 2014;273(2):401–9.
Sung J, Lee C, Morris E, Comstock C, Dershaw D. Patient follow-up after concordant histologically benign imaging-guided biopsy of MRI-detected lesions. AJR. 2012;198(6):1464–9.
Trop I, Labelle M, David J, Mayrand M, Lalonde L. Second-look targeted studies after breast magnetic resonance imaging: practical tips to improve lesion identification. Curr Probl Diagn Radiol. 2010;39(5):200–11.
Wiratkapun C, Duke D, Nordmann A, Lertsithichai P, Narra V, Barton P, et al. Indeterminate or suspicious breast lesions detected initially with MR imaging. Acad Radiol. 2008;15(5):618–25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Chhor, C., Newburg, A. (2017). Targeted Ultrasound After MRI. In: Heller, S., Moy, L. (eds) Breast Oncology: Techniques, Indications, and Interpretation. Springer, Cham. https://doi.org/10.1007/978-3-319-42563-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-42563-4_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42561-0
Online ISBN: 978-3-319-42563-4
eBook Packages: MedicineMedicine (R0)